Affiliation:
1. Student Research Group at the I Department of Psychiatry, Psychotherapy and Early Intervention , Medical University of Lublin , Poland
2. I Department of Psychiatry, Psychotherapy, and Early Intervention , Medical University of Lublin , Poland
Abstract
Abstract
Introduction: Homocysteine is an endogenous sulfur amino acid, formed as a result of biochemical changes in methionine. The normal concentration of homocysteine in healthy people is within the range of 5 - 15 µmol / l, and values above 15 µmol / l are referred to as hyperhomocysteinemia. Moreover, it has been shown that the level of homocysteine may be associated with the occurrence of mental disorders. The aim of this article was to search for a relationship between the level of this amino acid and the incidence and prognosis of bipolar disorder, depression, anxiety disorders, schizophrenia or Alzheimer’s disease.
Material and method: For the review of the literature, available articles from the PubMed database and Google Scholar were used under the following keywords: homocysteine, depression, bipolar disorder, schizophrenia, Alzheimer’s disease in the period from 1992 to 2021.
Results: The research conducted so far shows that there is a significant correlation between elevated levels of homocysteine and the above-mentioned mental disorders.
Conclusion: In order to prevent the consequences of the increased level of homocysteine, its concentration in blood serum should be monitored periodically and appropriate treatment should be implemented in case of abnormal results. It is important to educate patients about the consequences of hyperhomocysteinemia i.a. atherosclerosis, stroke, ischemic heart disease, osteoporosis, neural tube defects, mental disorders and neurodegenerative diseases. It should be also established a strategy to lower the level of this amino acid through lifestyle changes, as well as the supply of folic acid, vitamins B12, B6, B2, N-acetylcysteine and betaine.
Subject
Psychiatry and Mental health,Clinical Psychology
Reference86 articles.
1. 1. Magott M. Homocysteina nielipidowym czynnikiem patogenezy miażdżycy. Post. Hig. Med. Dośw. 1998; 52 (3): 259–267.
2. 2. McCully K.S. Homocysteine and vascular disease. Nat. Med. 1969; 2: 386–389.
3. 3. Łubińska M, Kazimierska E, Sworczak K. Hyperhomocysteinemia as a New Factor for Different Diseases. AdvClinExp Med. 2006; 15(5): 897-903.
4. 4. Skovierova H, Vidomanova E, Mahmood S, Sopkova J, Drgova A, Cervenova T, et. al. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int J Mol Sci. 2016
5. 17(10): 1733.10.3390/ijms17101733